全文获取类型
收费全文 | 1823篇 |
免费 | 79篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 40篇 |
妇产科学 | 11篇 |
基础医学 | 176篇 |
口腔科学 | 17篇 |
临床医学 | 111篇 |
内科学 | 397篇 |
皮肤病学 | 28篇 |
神经病学 | 125篇 |
特种医学 | 71篇 |
外科学 | 295篇 |
综合类 | 11篇 |
预防医学 | 27篇 |
眼科学 | 172篇 |
药学 | 213篇 |
中国医学 | 1篇 |
肿瘤学 | 182篇 |
出版年
2022年 | 10篇 |
2021年 | 28篇 |
2020年 | 16篇 |
2019年 | 27篇 |
2018年 | 36篇 |
2017年 | 26篇 |
2016年 | 39篇 |
2015年 | 48篇 |
2014年 | 44篇 |
2013年 | 49篇 |
2012年 | 127篇 |
2011年 | 103篇 |
2010年 | 63篇 |
2009年 | 54篇 |
2008年 | 83篇 |
2007年 | 109篇 |
2006年 | 91篇 |
2005年 | 92篇 |
2004年 | 85篇 |
2003年 | 69篇 |
2002年 | 78篇 |
2001年 | 62篇 |
2000年 | 55篇 |
1999年 | 67篇 |
1998年 | 30篇 |
1997年 | 22篇 |
1996年 | 14篇 |
1995年 | 14篇 |
1994年 | 5篇 |
1992年 | 31篇 |
1991年 | 37篇 |
1990年 | 31篇 |
1989年 | 33篇 |
1988年 | 22篇 |
1987年 | 21篇 |
1986年 | 19篇 |
1985年 | 20篇 |
1984年 | 16篇 |
1983年 | 8篇 |
1979年 | 14篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1974年 | 5篇 |
1972年 | 5篇 |
1971年 | 7篇 |
1970年 | 10篇 |
1969年 | 9篇 |
1968年 | 9篇 |
1967年 | 10篇 |
1966年 | 6篇 |
排序方式: 共有1907条查询结果,搜索用时 15 毫秒
81.
Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma 总被引:9,自引:3,他引:6
Suzuki S Sakaguchi T Yokoi Y Okamoto K Kurachi K Tsuchiya Y Okumura T Konno H Baba S Nakamura S 《World journal of surgery》2002,26(6):687-693
The clinicopathological characteristics relevant to prognosis after surgical treatment of intrahepatic cholangiocarcinoma (ICC) remain unclear. In this study, the clinicopathological features of 19 patients with mass-forming ICC, the most common form of the disease, were reviewed to analyze prognostic determinants. Two or more segmentectomies of the liver with systematic lymphadenectomy were performed in 18 patients. Resection of the extrahepatic bile duct was performed in 14 patients, and reconstruction of the portal vein was accomplished in 5 patients. Stage IVA or IVB tumors were seen in 13 patients, and lymph node (LN) metastasis was present in 14 patients. The estimated 5-year survival rate after surgery for mass-forming ICC was 28%, with median survival time of 18 months. In univariate analysis, five variables were determined to be significantly correlated with poor survival of patients with mass-forming ICC after surgery. These variables include mass-forming ICC with periductal infiltration, perineural invasion, portal vein invasion, presence of intrahepatic metastasis, and two or more LN metastases. Survival rates of 5 patients without LN metastasis and 6 patients with a single LN metastasis were 80% and 33% at 5 years, respectively, while 8 patients with two or more LN metastasis failed to survive beyond 2 years. Multivariate analysis revealed the presence of intrahepatic metastasis to be an independent prognostic factor of poor survival. Hepatectomy with resection of the extrahepatic bile duct and systematic lymphadenectomy yields a good chance for prolonged survival for patients with mass-forming ICC when the lesion is singular and LN metastasis is limited to a regional LN. Because the presence of intrahepatic metastasis was closely related to a poor prognosis in patients with mass-forming ICC, efficacious chemotherapy would be needed to control development of the lesion. 相似文献
82.
Nicotine is widely consumed throughout the world, and exerts a number of physiological effects. After nicotine is absorbed through the lungs by cigarette smoking, it undergoes extensive metabolism in humans. Nicotine is mainly metabolized to cotinine by cytochrome P450 (CYP) 2A6. CYP2A6 can metabolize some pharmaceutical agents such as halothane, valproic acid, and fadrozole, and activate tobacco-specific nitrosamines. There are large interindividual differences in nicotine metabolism, and it has been found that the interindividual differences are attributed to the genetic polymorphisms of CYP2A6 gene. This review describes the techniques for determination of in vivo nicotine metabolism, characteristics of each human CYP2A6 alleles, and ethnic differences. The relationship between CYP2A6 genetic polymorphism and potency of nicotine metabolism, smoking behavior, and cancer risk are extensively reviewed. Finally, the usefulness of nicotine metabolism for phenotyping of CYP2A6 in individuals and implication of the significance of CYP2A6 genetic polymorphism in a clinical perspective are discussed. 相似文献
83.
Owa T Yokoi A Yamazaki K Yoshimatsu K Yamori T Nagasu T 《Journal of medicinal chemistry》2002,45(22):4913-4922
84.
85.
Kim ES Soffer SZ Huang J McCrudden KW Yokoi A Manley CA Middlesworth W Kandel JJ Yamashiro DJ 《Journal of pediatric surgery》2002,37(3):518-522
Background: The authors have shown previously that experimental neuroblastoma is partially inhibited (48%) by antivascular endothelial growth factor (anti-VEGF) antibody. The topoisomerase-I inhibitor, topotecan, has been shown to have antiangiogenic activity when administered in a low-dose, high-frequency regimen. We hypothesized that combining topotecan with anti-VEGF would suppress neuroblastoma more effectively than either agent alone. Methods: A total of 106 neuroblastoma cells were implanted intrarenally in athymic mice. Animals received vehicle, topotecan, anti-VEGF, or topotecan plus anti-VEGF (n = 9, 20, 20, 20, respectively). All control and half the treated mice were killed at 6 weeks. Remaining (rebound) mice were maintained without treatment for 3 more weeks. Patterns of vasculature and apoptosis were determined immunohistochemically. Results: Tumor weights at 6 weeks were reduced significantly in topotecan-only (0.07g) and combination-treated animals (0.08 g), compared with controls or anti-VEGF[ndash ]treated mice (1.18 g, 0.53 g; P [lt ] .0007, all). At 9 weeks, rebound tumor weights were greatest in anti-VEGF (2.82 g), intermediate in topotecan (1.82 g), and least in combination-treated animals (1.47 g); however, the only significant difference was between anti-VEGF and combination therapy (P = 0.04). All treated tumors were vascularized sparsely in comparison with controls at 6 weeks, but exhibited brisk neoangiogenesis at 9 weeks. Conclusions: Topotecan either with or without anti-VEGF antibody significantly suppresses neuroblastoma xenograft growth in comparison with controls or anti-VEGF antibody alone. Combining topotecan with anti-VEGF antibody significantly inhibited rebound tumor growth in comparison with anti-VEGF antibody alone. Combination therapy may improve durability of antiangiogenic inhibition of neuroblastoma. 相似文献
86.
The purpose of the present study was to determine the effect of graded amounts of dietary selenium on plasma and tissue parameters of methionine metabolism including homocysteine. Male weanling Fisher-344 rats (n = 7-8/group) were fed a selenium-deficient, torula yeast-based diet, supplemented with 0 (selenium deficient), 0.02, 0.05 or 0.1 microg (adequate) selenium (as selenite)/g diet. After 61 d, plasma total homocysteine and cysteine were decreased (P < 0.0001) and glutathione increased (P < 0.0001) by selenium deficiency. The concentrations of homocysteine in kidney and heart were decreased (P = 0.02) by selenium deficiency. The activities of liver betaine homocysteine methyltransferase, methionine synthase, S-adenosylmethionine synthase, cystathionine synthase and cystathionase were determined; selenium deficiency affected only betaine homocysteine methyltransferase, which was decreased (P < 0.0001). The ratios of plasma free reduced homocysteine (or cysteine) to free oxidized homocysteine (or cysteine) or to total homocysteine (or cysteine) were increased by selenium deficiency, suggesting that selenium status affects the normally tightly controlled redox status of these thiols. Most differences due to dietary selenium were between rats fed 0 or 0.02 microg selenium/g diet and those fed 0.05 or 0.1 microg selenium/g diet. The metabolic consequences of a marked decrease in plasma homocysteine and smaller but significant decreases in tissue homocysteine are not known. 相似文献
87.
Yamada T Ishida K Yokoi S Nakano M Ehara H Takahashi Y Ishihara S Deguchi T 《Hinyokika kiyo. Acta urologica Japonica》2002,48(7):431-434
We report a case of ACTH-independent macronodular adrenal hyperplasia (AIMAH). A 62-year-old man was admitted to our hospital for further examination of obesity and diabetes mellitus. He was diagnosed with Cushing's syndrome by endocrinological examinations, and computed tomography and magnetic resonance imaging findings revealed nodular hyperplasia in bilateral adrenal glands, suggesting its etiology to be AIMAH. We underwent simultaneous bilateral laparoscopic adrenalectomy. A preoperative diagnosis of AIMAH was confirmed by histological examination of both adrenal glands, weighing 21 g (right) and 16 g (left). The postoperative course was uneventful. We believe that simultaneous bilateral laparoscopic adrenalectomy is feasible, safe, and results in minimal postoperative morbidity for the treatment of AIMAH. 相似文献
88.
HIT type II is one of the severe complications of heparin therapy. The antibody for the heparin-PF 4 complex, which causes thrombocytopenia of less than 100 x 10(3).microliter-1, thrombosis and DIC-like symptoms, is produced. We managed the patient with HIT type II, who underwent off-pump CABG using argatroban, a direct thrombin inhibitor, as an anticoagulant. Intraoperative activated coagulation time (ACT) was maintained above 250 sec with 5.0 micrograms.kg-1.min-1 of argatroban infusion and all the procedures were successful. We also investigated the platelet count in the 100 patients with heparin therapy in CCU. The incidence of the platelet depression after heparin administration was as high as 59%, and in 12% of the patients the platelet count dropped below 100 x 10(3).microliter-1. In conclusion, thrombocytopenia by heparin therapy is not rare, and argatroban as an anticoagulant during off-pump CABG is thought to be useful. 相似文献
89.